258d
From Proteopedia
OCA (Talk | contribs)
(New page: 200px<br /><applet load="258d" size="350" color="white" frame="true" align="right" spinBox="true" caption="258d, resolution 1.580Å" /> '''FACTORS AFFECTING S...)
Next diff →
Revision as of 15:49, 29 January 2008
|
FACTORS AFFECTING SEQUENCE SELECTIVITY ON NOGALAMYCIN INTERCALATION: THE CRYSTAL STRUCTURE OF D(TGTACA)-NOGALAMYCIN
Overview
As part of an investigation into the sequence selectivity of the, nogalamycin-DNA interaction, the 1.58 A structure of nogalamycin complexed, with d5'(TGTACA)2 has been determined by single-crystal X-ray analysis., The complex crystallised in the orthorhombic space group P2(1)2(1)2(1), with cell dimensions a = 26.3 A, b = 52.0 A and c = 67.1 A, incorporating, two B-DNA duplexes and four nogalamycin molecules in the asymmetric unit., The final refined structure included 97 water molecules, one spermine, molecule, two acetate ions and one sodium ion, yielding an overall R, factor of 19.2% (calculated using all 12,358 reflections in the resolution, range 10.7 to 1.6 A) and an Rtree of 23.7% (using 1229 test reflections)., The d5'(TGTACA)2 sequence was designed to include the d5'(TpG), pyrimidine-purine base step that has been ascertained as a preferential, intercalation site. The complexes in the asymmetric unit are globally, similar; one nogalamycin molecule intercalates between each d5'(TpG) step, in each duplex. The DNA of each complex exists as a distorted B-DNA duplex, displaying some Z-DNA character in the form of C3' endo sugars at some, residues. Structural comparisons between the d5'(TGTACA)2-nogalamycin2, complex and the complexes of this drug with the sequences d5'(TGATCA)2 and, d5'(5MeCGT(pS)A5MeCG)2 highlight differences in binding interactions, between nogalamycin and these various triplet DNA binding sites, with, regards to the stability of drug intercalation, which in turn is, correlated to effective levels of cytotoxicity towards tumour cells. The, number of both direct and water-mediated hydrogen bonds and van der Waal's, interactions between substituents of nogalamycin and the d5'(TGTACA)2 and, d5'(5MeCGT(pS)A5MeCG)2 sequences are significantly greater than those made, with the d5'(TGATCA)2 sequence, suggesting that the central d5'(TpA) in, the former confers additional stability to the complex once the drug has, bound.
About this Structure
258D is a Protein complex structure of sequences from [1] with , , and as ligands. Full crystallographic information is available from OCA.
Reference
Factors affecting DNA sequence selectivity of nogalamycin intercalation: the crystal structure of d(TGTACA)2-nogalamycin2., Smith CK, Brannigan JA, Moore MH, J Mol Biol. 1996 Oct 25;263(2):237-58. PMID:8913304
Page seeded by OCA on Tue Jan 29 17:49:30 2008
Categories: Protein complex | Brannigan, J.A. | Moore, M.H. | Smith, C.K. | ACT | NA | NGM | SPM | B-dna | Complexed with drug | Double helix